Iron-Single-Atom Nanozyme with NIR Enhanced Catalytic Activities for Facilitating MRSA-Infected Wound Therapy.
Qian LiuXueliang LiuXiaojun HeDanyan WangChen ZhengLin JinJianliang ShenPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Patients with methicillin-resistant Staphylococcus aureus (MRSA) infections may have higher death rates than those with non-drug-resistant infections. Nanozymes offer a promising approach to eliminating bacteria by producing reactive oxygen species. However, most of the conventional nanozyme technologies encounter significant challenges with respect to size, composition, and a naturally low number of active sites. The present study synthesizes a iron-single-atom structure (Fe-SAC) via nitrogen doped-carbon, a Fe-N 5 catalyst (Fe-SAC) with a high metal loading (4.3 wt.%). This catalyst permits the development of nanozymes consisting of single-atom structures with active sites resembling enzymes, embedded within nanomaterials. Fe-SAC displays peroxidase-like activities upon exposure to H 2 O 2 . This structure facilitates the production of hydroxyl radicals, well-known for their strong bactericidal effects. Furthermore, the photothermal properties augment the bactericidal efficacy of Fe-SAC. The findings reveal that Fe-SAC disrupts the bacterial cell membranes and the biofilms, contributing to their antibacterial effects. The bactericidal properties of Fe-SAC are harnessed, which eradicates the MRSA infections in wounds and improves wound healing. Taken together, these findings suggest that single Fe atom nanozymes offer a novel perspective on the catalytic mechanism and design, holding immense potential as next-generation nanozymes.
Keyphrases
- methicillin resistant staphylococcus aureus
- metal organic framework
- drug resistant
- staphylococcus aureus
- visible light
- wound healing
- molecular dynamics
- aqueous solution
- reactive oxygen species
- multidrug resistant
- single cell
- acinetobacter baumannii
- climate change
- stem cells
- nitric oxide
- candida albicans
- cystic fibrosis
- carbon dioxide
- reduced graphene oxide
- cancer therapy
- smoking cessation
- replacement therapy